Fresenius Medical Care (FMS) reported Q3 adjusted earnings Tuesday of 1.10 euros ($1.27) per share, up from 0.81 euros a year earlier.
Comparable analyst estimates were not readily available.
Revenue for the quarter ended Sept. 30 was 4.89 billion euros, up from 4.76 billion euros a year earlier.
Analysts surveyed by FactSet expected 4.96 billion euros.
Shares of the company were down 6.8% in premarket activity.